This work is licensed under a Creative Commons Attribution 4.0 International License.
AMP2041
General Information
DRACP ID DRACP03559
Peptide Name AMP2041
Sequence HKCAKIKWRGVHVKYCA
Sequence Length 17
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antibacterial
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C92H147N29O19S2
Absent amino acids DEFLMNPQST
Common amino acids K
Mass 231307
Pl 10.49
Basic residues 7
Acidic residues 0
Hydrophobic residues 6
Net charge 7
Boman Index -2413
Hydrophobicity -44.71
Aliphatic Index 68.82
Half Life
Mammalian: 1.3 hour
Yeast: 3 min
E.coli: 2 min
Extinction Coefficient cystines 7115
Absorbance 280nm 444.69
Polar residues 4
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 28335779
Title Activity of AMP2041 against human and animal multidrug resistant Pseudomonas aeruginosa clinical isolates
Doi Not available
Year 2017
Literature 2
Pubmed ID 23893489
Title In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens
Doi Not available
Year 2013
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID 7559
This work is licensed under a Creative Commons Attribution 4.0 International License.